Biogen creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen’s significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For product labeling, press releases and additional information about the company, please visit www.biogen.com.
Apr 01, 2021
Posted by Biogen